insulin-like growth factor-1 (Sarcomed AB)

N/A

Report date: 2025/03/20 15:58:42
NME

Base Information

Drug Nameinsulin-like growth factor-1 (Sarcomed AB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor modulators
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsPhelan-McDermid syndromeBulbo-Spinal Atrophy, X-LinkedMuscular Dystrophy, Duchenne +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSarcomed AB
China Registration ClassN/A

Develop Information

Active CompaniesSarcomed AB
Inactive CompaniesN/A
Active IndicationsPhelan-McDermid syndromeBulbo-Spinal Atrophy, X-LinkedMuscular Dystrophy, Duchenne +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A